Zenas BioPharma Inc. (ZBIO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 665 |
% of all portfolios: | 0.006% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
15 |
$82,089,719 |
Sells |
0 |
$0 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
20 Nov 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
19 Nov 2024 |
2,500 |
14.57 |
36,425 |
20 Nov 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
18 Nov 2024 |
7,500 |
15.00 |
112,500 |
20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
20 Sep 2024 |
2,633 |
18.97 |
49,948 |
20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
20 Sep 2024 |
2,367 |
17.88 |
42,322 |
20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
19 Sep 2024 |
5,000 |
17.89 |
89,450 |
20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
18 Sep 2024 |
10,000 |
17.91 |
179,100 |
18 Sep 2024 |
ENAVATE SCIENCES GP, LLC |
10% |
16 Sep 2024 |
882,353 |
17.00 |
15,000,001 |
17 Sep 2024 |
LU HONGBO |
Director |
13 Sep 2024 |
58,823 |
17.00 |
999,991 |
16 Sep 2024 |
ENRIGHT PATRICK G |
Director |
16 Sep 2024 |
440,000 |
17.00 |
7,480,000 |
16 Sep 2024 |
NUNN JASON RALEIGH |
Director |
16 Sep 2024 |
441,176 |
17.00 |
7,499,992 |
16 Sep 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director |
16 Sep 2024 |
300,000 |
17.00 |
5,100,000 |
16 Sep 2024 |
SR ONE CAPITAL MANAGEMENT, LLC |
10% |
16 Sep 2024 |
1,352,942 |
17.00 |
23,000,014 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock